NetworkNewsBreaks

TuesdaySep 24, 2024 12:27 pm

NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Names Industry Expert, Pioneer as New Chief AI Scientist

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient is, has appointed a new chief artificial intelligence (“AI”) scientist: Lance Myers, PhD. According to the announcement, Myers is the former head of data science at Verily, formerly Google Life Sciences. A renowned industry leader and pioneer in digital health data analytics and body-worn biosensor technologies, Myers is a globally respected authority on utilizing AI in biosensor tech. In his new position, Myers will drive innovation and strategic growth for HeartBeam as the company looks to fully leverage its AI…

Continue Reading

TuesdaySep 24, 2024 12:17 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Awarded DV Electronic Monitoring Contract by Government of European Country

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has secured a three-year national contract with the government of a European country. The contract calls for SuperCom deploy its PureSecurity domestic violence (“DV”) monitoring solution. Since entering the market, SuperCom has become a leader in Europe’s national domestic violence monitoring sector, deploying a substantial number of units and outpacing its competitors. This new contract further solidifies the company’s continued expansion in the region as it works to enhancing domestic violence prevention and intervention capabilities. “We are honored to collaborate with this…

Continue Reading

TuesdaySep 24, 2024 11:15 am

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Shares Video Update from CEO

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today shared a video update to shareholders provided by CEO and Chairman David Michery. In the video, Michery provides a detailed overview of the company’s recent progress, including sales and distribution expansion and financial performance. According to the update, the company’s sales activities with existing and new companies have resulted in new sales opportunities and vehicle orders received and or completed. Additionally, Mullen has secured financing to support sales growth through a $100 million preferred instrument and a $150 million fully available equity line. The update also highlighted Bollinger Motors’…

Continue Reading

TuesdaySep 24, 2024 10:00 am

NetworkNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Announces Receipt of Notice of Allowance for China Patent Application Covering AVERSA(TM) Technology

Nutriband (NASDAQ: NTRB), a pharmaceutical company with a special focus on transdermal technologies, is announcing that its patent application, which protects its AVERSA(TM) abuse deterrent transdermal technology, has been allowed in China. This follows the receipt of a Notice of Allowance from the Chinese National Intellectual Property Administration (“CNIPA”) for the application entitled “Abuse and Misuse Deterrent Transdermal Systems.” The latest allowance expands the company’s international intellectual property portfolio, which now includes patents issued in 46 countries: Australia, Canada, China, Europe, Japan, Korea, Mexico, Russia, the U.S., and more. To view the full press release, visit https://nnw.fm/GJOFB About Nutriband Inc.…

Continue Reading

MondaySep 23, 2024 1:32 pm

NetworkNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN), Subsidiary Celebrate Production of B4 Electric Truck, CEO to Release Shareholder Update Video

Mullen Automotive (NASDAQ: MULN), an electric vehicle (“EV”) manufacturer, and its subsidiary, Bollinger Motors, are announcing a major milestone. According to the announcement, the first customer-ready B4 electric truck rolled off the production line in Livonia, Michigan, last week. Employees, suppliers and government officials gathered on Sept. 20, 2024, to celebrate the production of the first customer-ready, all-electric Class 4 Bollinger B4 Chassis Cab. The vehicle, which is produced in partnership with Roush Industries, is entirely assembled in the United States. “Robert Bollinger and his team made a gutsy call two years ago to pivot to an entirely different market…

Continue Reading

MondaySep 23, 2024 1:13 pm

NetworkNewsBreaks – Snap Inc. (NYSE: SNAP) Introduces AI-Generated ‘My Selfie’ Feature Amid Privacy Concerns

Snap (NYSE: SNAP), the parent company of the popular social media platform Snapchat, has recently introduced a groundbreaking feature named “My Selfie.” This innovative tool leverages artificial intelligence (“AI”) to generate images of users’ faces, which can be utilized in various in-app experiences, including advertisements. This move by Snap Inc. is a significant step towards integrating AI technology into social media, aiming to enhance user engagement and open new avenues for personalized advertising. The “My Selfie” feature is designed to allow users and their friends to create AI-generated images from their selfies, offering a unique and customized experience within the…

Continue Reading

MondaySep 23, 2024 11:20 am

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Participation at the 24th Annual Biotech in Europe Forum

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that CEO John Climaco will present at the 24th Annual Biotech in Europe Forum. The presentation is scheduled for Wednesday, September 25, 2024, at 1:55 p.m. CEST in Basel, Switzerland. Additionally, management will participate in in-person one-on-one meetings with qualified members of the investor community who are registered to attend the conference. To view the full press release, visit https://nnw.fm/tantX About CNS Pharmaceuticals Inc. CNS Pharmaceuticals is a clinical-stage pharmaceutical company developing…

Continue Reading

MondaySep 23, 2024 10:45 am

NetworkNewsBreaks – TC Biopharm (Holdings) PLC (NASDAQ: TCBP) Completes ACHIEVE Trial Full-Dose Regimen for First Patient

TC Biopharm (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, has announced a key step in its ACHIEVE clinical trial. According to the announcement, the first patient has completed the full-dose regimen in the phase 2b trial. In addition, the company announced that six patients have received a second dose and three patients have received a third dose; patients can receive up to four total doses of TCB under the trial protocol. Furthermore, no TCB008-related adverse events have been observed in any of the restart patients. To view the full press release, visit…

Continue Reading

MondaySep 23, 2024 10:44 am

NetworkNewsBreaks – Dynasty Gold Corp.’s (TSX.V: DYG) (FSE: D5G1) (OTC: DGDCF) Initial Assay Results from 2024 Drill Program Demonstrate ‘Richness of the Gold System’ at Thundercloud

Dynasty Gold (TSX.V: DYG) (FSE: D5G1) (OTC: DGDCF), a Canadian mineral exploration company, today announced assay results for the first phase of the 2024 drill program at its Thundercloud property. The program comprises 2,198 meters. According to the announcement, drilling successfully intersected high-grade gold mineralization of 5.13 g/t Au over 18 meters from 97.5m to 115.5m, including 9.3 g/t Au over 4.5 meters and numerous 5 to 8+ g/t Au over 1.5m in drillhole TC24-02 (30 meters additional assay results are pending). In addition, drilling intersected broad zones of lower grade mineralization from 25 meters below surface with intercepts between…

Continue Reading

MondaySep 23, 2024 10:08 am

NetworkNewsBreaks – Gaxos.ai Inc. (NASDAQ: GXAI) Enters into $3.24M Definitive Agreement

Gaxos.ai Inc. (NASDAQ: GXAI), a company developing artificial intelligence applications across various sectors, has entered into a definitive agreement for the exercise of certain existing warrants. The agreement outlines the purchase of 1,256,734 shares of certain of its common stock at a reduced exercise price of $2.58 per share. According to the announcement, the offering is expected to close today, subject to closing conditions. The company plans to use funds from the offering, which is anticipated to total an estimated $3.24 million before standard deductions and fees, for working capital and other general corporate purposes. H.C. Wainwright & Co. is…

Continue Reading